Abstract
Based on the perspectives of health service providers and medical insurance, the economic value evidence of multi-genotype HPV detection technology in cervical cancer screening strategies was analyzed and produced, and suggestions were provided for relevant decision-making of health administrative departments and hospitals.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
